Please wait
0001936258EX-FILING FEESUnallocated (Universal) Shelf 0001936258 2025-02-28 2025-02-28 0001936258 2 2025-02-28 2025-02-28 0001936258 3 2025-02-28 2025-02-28 0001936258 4 2025-02-28 2025-02-28 0001936258 5 2025-02-28 2025-02-28 0001936258 6 2025-02-28 2025-02-28 0001936258 7 2025-02-28 2025-02-28 0001936258 1 2025-02-28 2025-02-28 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
NewAmsterdam Pharma Company N.V.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
 
                 
    
Security
Type
 
Security
Class
Title
 
Fee
Calculation
Rule
 
Amount
Registered
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
Registration
Fee
                 
Fees to be Paid   Equity   Ordinary Shares, nominal value EUR 0.12   Rule 457(o)   (1)   $(1)   $—     $—
  Debt   Debt Securities   Rule 457(o)   (1)   $(1)      
  Other   Warrants   Rule 457(o)   (1)   $(1)      
  Other   Subscription Rights   Rule 457(o)   (1)   $(1)      
  Other   Purchase Contracts   Rule 457(o)   (1)   $(1)      
  Other   Units   Rule 457(o)   (1)   $(1)      
 
Unallocated (Universal) Shelf
    Rule 457(o)   $500,000,000     $500,000,000(2)   0.00015310   $76,550.00
                 
Fees Previously
Paid
  N/A   N/A   N/A   N/A   N/A   N/A   N/A   N/A
           
    Total Offering Amounts     $500,000,000(2)     $76,550.00
           
    Total Fees Previously Paid         $
           
    Total Fee Offsets         $
           
    Net Fee Due               $76,550.00
 
(1)
An indeterminate number or aggregate principal amount, as applicable, of securities of each identified class is being registered as may from time to time be offered on a primary basis at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional securities of the registrant that become issuable by reason of any splits, dividends or similar transactions or anti-dilution adjustments.
(2)
Estimated solely for the purpose of calculating the registration fee. Subject to Rule 462(b) under the Securities Act, the aggregate initial offering price of all securities issued by the registrant pursuant to this registration statement will not exceed $500.0 million.